Cargando…

Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients

Colorectal cancer (CRC) ranks among the most common cancers worldwide. Surgical removal remains the best strategy for treatment of resectable tumors. An important part of caring for patients after surgery is monitoring for early detection of a possible relapse of the disease. Efforts are being made...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pesta, Martin, Kucera, Radek, Topolcan, Ondrej, Karlikova, Marie, Houfkova, Katerina, Polivka, Jiri, Macanova, Tereza, Machova, Iva, Slouka, David, Kulda, Vlastimil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627112/ https://www.ncbi.nlm.nih.gov/pubmed/31234350 http://dx.doi.org/10.3390/cancers11060864

Ejemplares similares

The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases
por: Polivka, Jiri, et al.
Publicado: (2020)

Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
por: Pesta, Martin, et al.
Publicado: (2022)

Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients—Comparison with the Standard Histopathological Procedure
por: Vodicka, Josef, et al.
Publicado: (2020)

Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations
por: Polivka, Jiri, et al.
Publicado: (2014)

Education in personalized medicine in Czech Republic
por: Karlikova, Marie, et al.
Publicado: (2014)

May CTC technologies promote better cancer management?
por: Pesta, Martin, et al.
Publicado: (2015)

Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients
por: Pesta, Martin, et al.
Publicado: (2014)

The Stability of the Anti-Müllerian Hormone in Serum and Plasma Samples under Various Preanalytical Conditions
por: Vrzáková, Radana, et al.
Publicado: (2023)

The application of personalized medicine in neurooncology
por: Polivka Jr, Jiri, et al.
Publicado: (2014)

Epidemiological and Microbiological Aspects of the Peritonsillar Abscess
por: Slouka, David, et al.
Publicado: (2020)

Current status of biomarker research in neurology
por: Polivka, Jiri, et al.
Publicado: (2016)

IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme
por: Polívka, Jiří, et al.
Publicado: (2018)

Stroke care in West Bohemia – personalised medicine approach
por: Polivka, Jiri, et al.
Publicado: (2014)

Informed Consent in the Newly Established Biobank
por: Kinkorová, Judita, et al.
Publicado: (2019)

Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic
por: Reischig, Tomas, et al.
Publicado: (2022)

The activities of the young professionals EPMA in the Czech Republic
por: Polivka Jr , Jiri, et al.
Publicado: (2014)

Isocitrate Dehydrogenase-1 Mutations as Prognostic Biomarker in Glioblastoma Multiforme Patients in West Bohemia
por: Polivka, J., et al.
Publicado: (2014)

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020
por: Golubnitschaja, Olga, et al.
Publicado: (2020)

Long-Term Monitoring of the Antibody Response to a SARS-CoV-2 Infection
por: Šimánek, Václav, et al.
Publicado: (2021)

Serum levels of markers in early detection of prostate cancer (pilote study)
por: Fuchsova, Radka, et al.
Publicado: (2014)

Prostate Cancer Diagnostic Algorithm as a “Road Map” from the First Stratification of the Patient to the Final Treatment Decision
por: Sedláčková, Hana, et al.
Publicado: (2021)

Optimal Use of Biomarkers in Oncology
por: Karlikova, Marie, et al.
Publicado: (2015)

Prognostic value of tumor markers in malignant melanoma
por: Treskova, Inka, et al.
Publicado: (2014)

Establishing Biobanking in Medical Curricula—The Education Program “Precision Medicine International” (eduBRoTHER)
por: Seidler, Deborah, et al.
Publicado: (2023)

The Clinical Significance of CEA, CA19–9, and CA125 in Management of Appendiceal Adenocarcinoma
por: Yousef, Abdelrahman, et al.
Publicado: (2023)

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
por: Šimánek, Václav, et al.
Publicado: (2021)

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
por: Lakemeyer, Leilani, et al.
Publicado: (2021)

Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels
por: Ata, Naim, et al.
Publicado: (2014)

Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
por: Sachan, Ashish, et al.
Publicado: (2020)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei
por: Liang, Lei, et al.
Publicado: (2021)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.
por: Nilsson, O., et al.
Publicado: (1992)

An Assessment of Novel Biomarkers in Bone Metastatic Disease Using Multiplex Measurement and Multivariate Analysis
por: Windrichova, Jindra, et al.
Publicado: (2018)

Comparison of four routinely used vitamin D automated immunoassays
por: Windrichova, Jindra, et al.
Publicado: (2021)

Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
por: Lee, Kyong Joo, et al.
Publicado: (2013)

Reversible high blood CEA and CA19-9 concentrations in a diabetic patient
por: Chen, Pei-Chi, et al.
Publicado: (2012)

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma
por: Vukobrat-Bijedic, Zora, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_63hn52gi5msbvo5l9465k2bcbu